DIFFICIL-S® has been independently tested by NHS laboratories to give at least a 5 log reduction of 99.999% in Clostridium difficile (including spores), MRSA, Norovirus, Listeria, E.coli, Salmonella, Pseudomonas, Mycobacteria (tubercle bacilli) and other pathogens. DIFFICIL-S® has received a Recommendation Two from the Department of Health's Rapid Review Panel


OUR COMPANY


DIFFICIL-S® is part of the Cleankill range of infection control products manufactured by Clinimax Ltd.

Clinimax Ltd is a British company specializing in the research, development and manufacture of innovative infection control products for use by the healthcare profession.

Bio-security is of ever increasing importance in today’s world of new and potentially fatal pathogens. Micro-organisms are continually evolving and developing resistance to current drugs and disinfectants so that the emergence of new disease strains is a constant threat.

Our mission at Clinimax is to remain at the forefront of bio-security technology by continual research and development to improve our wide range of infection control products under the Cleankill branding.

All Cleankill products have been formulated exclusively in our own laboratories and have been independently tested and given a 5-log reduction against all known pathogens by University Hospital Birmingham NHS Foundation Trust research laboratories.

Contact us at Clinimax/Difficil-S


GroupShot

 

©2011 Clinimax Ltd